The Biobank of Nephrological Diseases in the Netherlands cohort: The String of Pearls Initiative collaboration on chronic kidney disease in the university medical centers in the Netherlands

Nephrology Dialysis Transplantation

Volumn 29, Issue 6, 2014, Pages 1145-1150

  Navis, Gerjan J ^a   Blankestijn, Peter J ^b   Deegens, Jeroen ^c   De Fijter, Johan W ^d   Homan Van Der Heide, Jaap J ^e   Rabelink, Ton ^d   Krediet, Raymond T ^e   Kwakernaak, Arjan J ^a   Laverman, Gozewijn D ^a   Leunissen, Karel M ^f   Van Paassen, Pieter ^f   Vervloet, Marc G ^g   Wee, Pieter M Ter ^g   Wetzels, Jack F ^c   Zietse, Robert ^h   Van Ittersum, Frans J ^g  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

BIND NL; biobank; PSI; chronic kidney disease; renal data shaper; String of Pearls Initiative

Indexed keywords

CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DATA ANALYSIS; EXPERIMENTAL DESIGN; FUNDING; GOVERNMENT REGULATION; HEALTH CARE FACILITY; HUMAN; NETHERLANDS; ORGANIZATIONAL DEVELOPMENT; ORGANIZATIONAL DOWNSIZING; ORGANIZATIONAL EFFICIENCY; PATIENT ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; REVIEW; STRING OF PEARL INITIATIVE; TOTAL QUALITY MANAGEMENT; UNIVERSITY HOSPITAL;

BIND-NL; BIOBANK; PSI; CHRONIC KIDNEY DISEASE; RENAL DATA SHAPER; STRING OF PEARLS INITIATIVE;

ACADEMIC MEDICAL CENTERS; ADULT; BIOLOGICAL SPECIMEN BANKS; COOPERATIVE BEHAVIOR; DATABASES, FACTUAL; FEMALE; HUMANS; INTERPROFESSIONAL RELATIONS; MALE; NEPHROLOGY; NETHERLANDS; PROGNOSIS; PROGRAM DEVELOPMENT; RENAL INSUFFICIENCY, CHRONIC;

EID: 84901816129     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft307     Document Type: Review

References (23)

1. Levey AS, Coresh J. Chronic kidney disease. Lancet 2012; 379: 165-180
2. Kerr M, Bray B, Medcalf J et al. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant. 2012; october 27, supp 3, iii73-80
3. Peeters P, Rublee D, Just PM et al. Analysis and interpretation of cost data in dialysis: review of Western European literature. Health Policy 2000; 54: 209-227 (Pubitemid 32012610)
4. Köttgen A. Genome-wide association studies in nephrology research. Am J Kidney Dis. 2010; 56: 743-758
5. Mischak H, Ioannidis JP, Argiles A et al. Implementation of proteomic biomarkers: making it work. Eur J Clin Invest 2012; 42: 1027-1036
6. Fortier I, Burton PR, Robson PJ et al. Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. Int J Epidemiol 2010; 39: 1383-1393
7. Uhlig K, Macleod A, Craig J et al. Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 2006; 70: 2058-2065. Epub 2006 Sep 27 (Pubitemid 44871367)
8. Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease Work Group. KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2013; 83 (Suppl 3): 1-150
9. Vegter S, Perna A, Postma MJ et al. Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol 2012; 23: 165-173
10. Zoccali C, Ruggenenti P, Perna A et al. REIN Study Group. Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. J Am Soc Nephrol 2011; 22: 1923-1930
11. Tonelli M, Muntner P, Lloyd A et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population- level cohort study. Lancet 2012; 380: 807-814
12. Fox CS, Matsushita K, Woodward M et al. Chronic Kidney Disease Prognosis Consortium.Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 2012; 380: 1662-1673
13. Eckardt KU, Bärthlein B, Baid-Agrawal S et al. The German Chronic Kidney Disease (GCKD) study: design and methods. Nephrol Dial Transplant 2012; 27: 1454-1460. Epub 2011 Aug 22
14. Feldman HI, Appel LJ, Chertow GM et al. Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. The Chronic Renal Insufficiency Cohort (CRIC) Study: design and methods. J Am Soc Nephrol 2003; 14(7 Suppl 2): S148-S153 (Pubitemid 36750511)
15. Imai E, Matsuo S, Makino H et al. Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol 2010; 14: 558-570. Epub 2010 Aug 11
16. Stengel B, Combe C, Jacquelinet C et al. The Chronic Kidney Disease - Renal Epidemiology and Information Network (CKDREIN) Cohort Study: objectives and methods. Nephrol Dial Transplant 2013, provisionally accepted
17. Van Zuilen AD, Wetzels JF, Blankestijn PJ et al. MASTERPLAN Study Group. Rationale and design of the MASTERPLAN study: multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners. J Nephrol 2005; 18: 30-34 (Pubitemid 40723750)
18. Moranne O, Froissart M, Rossert J et al. NephroTest Study Group. Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol 2009; 20: 164-171
19. Chambers JC, Zhang W, Lord GM et al. Genetic loci influencing kidney function and chronic kidney disease. Nat Genet 2010; 42: 373-375
20. Stolk RP, Rosmalen JG, Postma DS et al. Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study. Eur J Epidemiol. 2008; 23: 67-74
21. Brenchley PE, Lindholm B, Dekker FW et al. Translating knowledge of the human genome into clinical practice in nephrology dialysis and transplantation: the renal genome network (ReGeNet). Nephrol Dial Transplant 2006; 21: 2681-2683 (Pubitemid 44542214)
22. Ruggenenti P, Perna A, Gherardi G et al. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy. Lancet 1998; 352: 1252-1256 (Pubitemid 28470337)
23. Brenner BM, Cooper ME, de Zeeuw D et al. RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869